- Home
- QMCO vs CVKD Comparison
QMCO vs CVKD Comparison
Compare QMCO & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMCO
- CVKD
- Stock Information
- Founded
- QMCO 1980
- CVKD 2022
- Country
- QMCO United States
- CVKD United States
- Employees
- QMCO N/A
- CVKD N/A
- Industry
- QMCO Electronic Components
- CVKD Medicinal Chemicals and Botanical Products
- Sector
- QMCO Technology
- CVKD Health Care
- Exchange
- QMCO Nasdaq
- CVKD Nasdaq
- Market Cap
- QMCO 25.4M
- CVKD 26.3M
- IPO Year
- QMCO N/A
- CVKD 2023
- Fundamental
- Price
- QMCO $3.31
- CVKD $15.66
- Analyst Decision
- QMCO Hold
- CVKD Strong Buy
- Analyst Count
- QMCO 2
- CVKD 2
- Target Price
- QMCO $5.00
- CVKD $46.00
- AVG Volume (30 Days)
- QMCO 75.9K
- CVKD 81.0K
- Earning Date
- QMCO 11-13-2024
- CVKD 11-07-2024
- Dividend Yield
- QMCO N/A
- CVKD N/A
- EPS Growth
- QMCO N/A
- CVKD N/A
- EPS
- QMCO N/A
- CVKD N/A
- Revenue
- QMCO $285,238,000.00
- CVKD N/A
- Revenue This Year
- QMCO N/A
- CVKD N/A
- Revenue Next Year
- QMCO $0.11
- CVKD N/A
- P/E Ratio
- QMCO N/A
- CVKD N/A
- Revenue Growth
- QMCO N/A
- CVKD N/A
- 52 Week Low
- QMCO $2.22
- CVKD $5.40
- 52 Week High
- QMCO $18.00
- CVKD $32.55
- Technical
- Relative Strength Index (RSI)
- QMCO 45.64
- CVKD 50.92
- Support Level
- QMCO $4.22
- CVKD $16.25
- Resistance Level
- QMCO $4.99
- CVKD $19.97
- Average True Range (ATR)
- QMCO 0.64
- CVKD 1.91
- MACD
- QMCO -0.07
- CVKD -0.18
- Stochastic Oscillator
- QMCO 7.84
- CVKD 27.81
About QMCO Quantum Corporation
Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data. The company provides solutions for the entire data lifecycle. The company specialize in solutions for video, images, audio, and other large files. The company's portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The company's Primary Storage Software and Systems include Myriad All-Flash Software-Defined Storage, StorNext Hybrid Flash/Disk File Storage Software, and Unified Surveillance Platform Software. Secondary Storage Software and Systems include ActiveScale Object Storage Software and DXi Backup Appliances. The firm derives the majority of its revenue from United States.
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.